A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell travelling through the circulatory system. It has the shape, the size and the moving capabilities of leukocytes and could perhaps be well on its way – in a rolling motion of course – to revolutionize the minimally invasive treatment of…
Scientists at the University of Delaware and Princeton University have developed a method to monitor blood damage in real-time. “Our goal was to find a method that could detect red blood cell damage without the need for lab sample testing,” said Tyler Van Buren, an assistant professor of mechanical engineering with expertise in fluid dynamics. The researchers recently reported their technique…
Blood stem cells have a surprising ability. In addition to ensuring the continuous renewal of blood cells, they keep track of past infections so that faster and more effective immune responses can be triggered in the future.
The number of ridges has been increased and they have been made deeper to provide improved grip and comfort for the user. In addition, the cap rim overlaps the top of the tube, providing a better grip for the user of the Greiner Bio-One product.
Siemens Healthineers announced it is expanding its infectious disease testing capabilities to aid in the COVID-19 pandemic.
In a small clinical trial just granted approval, about 30 COVID-19 patients at Karolinska University Hospital may soon begin to receive blood plasma from people who have recovered from the disease. Sweden's Ethical Review Authority has approved the trial treatment, and its effectiveness will be evaluated in a study by researchers at Karolinska Institutet and the Karolinska University Hospital.…
Siemens Healthineers announced that its latest critical care testing solution, the RapidPoint 500e Blood Gas Analyzer, has received clearance from the U.S. Food and Drug Administration (FDA), and is now available in the U.S., Europe and countries requiring the CE mark. The analyzer generates blood gas, electrolyte, metabolite, CO-oximetry, and neonatal bilirubin results, which are used to…
Researchers have developed the first blood test that can accurately detect more than 50 types of cancer and identify in which tissue the cancer originated, often before there are any clinical signs or symptoms of the disease. In a paper published in the leading cancer journal Annals of Oncology, the researchers show that the test, which could eventually be used in national cancer screening…
The MiniCollect Capillary Blood Collection System launched by Greiner Bio-One in 2016, has an improved cap on all its blood collection tubes. The new version, designed for easier opening, has an increased number of ridges that are also deeper to improve grip and user comfort. The cap rim also overlaps the top of the tube to augment grip and ease opening. The capillary blood collection tubes offer…
Engineers at Rutgers University have created a tabletop device that combines a robot, artificial intelligence and near-infrared and ultrasound imaging to draw blood or insert catheters to deliver fluids and drugs. Their most recent research results, published in the journal Nature Machine Intelligence, suggest that autonomous systems like the image-guided robotic device could outperform people on…
A simple blood test coupled with artificial intelligence (AI) analysis could help spot the signs of a brain tumour sooner in patients. Brain tumour diagnosis is difficult: patients often see their family doctor (GP) several times before referral for a scan. However, research presented at the 2019 National Cancer Research Institute (NCRI) Cancer Conference in Glasgow last November suggests the…
Within the framework of an international study, Lund University and Skåne University Hospital have started treating patients with hemophilia with gene therapy, something that began in January this year. The hope is that the new treatment will significantly simplify everyday life for those with severe hemophilia. Hemophilia is a genetic disease where the body does not produce one of the clotting…
Does the blood we thought to know so well contain elements that had been undetectable until now? The answer is yes, according to a team of researchers. The scientistts from Inserm, Université de Montpellier and the Montpellier Cancer Institute (ICM) working at the Montpellier Cancer Research Institute (IRCM), have revealed the presence of whole functional mitochondria in the blood circulation.…
A team of physicists from McMaster University has developed a process to modify red blood cells so they can be used to distribute drugs throughout the body, which could specifically target infections or treat catastrophic diseases such as cancer or Alzheimer’s. The modified red blood cells are designed to circulate in the body for several weeks at a time, seeking out specific targets including…
A first-ever map of the human body’s immune cells has been created by scientists at SciLifeLab, providing medical research with a detailed description of the proteins in human blood. The open-access database offers medical researchers an unprecedented resource in the search for treatments for diseases. Published in the journal Science, the Blood Atlas resource is the latest database to be…
Using lipidomics, a technique that measures the composition of blood lipids at a molecular level, and machine learning, researchers at Lund University in Sweden have identified a blood lipid profile that improves the possibility to assess, several years in advance, the risk of developing type 2 diabetes. The blood lipid profile can also be linked to a certain diet and degree of physical activity.…
A University of Leeds spin-out company has secured £3.14m to develop a next generation drug that aims to prevent blood clots forming, without the risk of bleeding present in currently available drugs. Currently, anticoagulants have a relatively narrow margin between beneficial effects and undesirable bleeding, so new approaches are in demand. These could allow more patients that have a higher…
Proteins in our blood could in future help provide a comprehensive ‘liquid health check’, assessing our health and predicting the likelihood that we will we will develop a range of diseases. Preventative medicine programmes such as the UK National Health Service’s Health Check and Healthier You programmes are aimed at improving our health and reducing our risk of developing diseases. While…
T2 Biosystems, Inc., a leader in the development and commercialization of medical diagnostic products, and CARB-X, a global non-profit partnership dedicated to accelerating R&D innovation to address the rising global threat of drug-resistant bacteria, announced the granting of a CE mark to the T2Resistance Panel. With the CE mark, T2 Biosystems has met the requirements of the In-Vitro…
Ensuring the quality of blood donations is vital. Data collected during the various processes involved must be fully traceable and documented, the company Andreas Hettich GmbH emphasises. Based in Tuttlingen, Germany, the company has produced laboratory equipment for 115 years, today focusing on centrifuges and incubators and employing 420 people worldwide. Its new HettInfo II documents all steps…
A partnership between the Royal Stoke University Hospital, part of the University Hospitals of North Midlands NHS Trust, and a UK industry-leading medical devices company have been rewarded for its use of an innovative bioelectronic technology to prevent life-threatening blood clots in acute stroke patients – winning in the category: Best use of technology (acute care), at the Building Better…
For the first time, researchers from Helmholtz Zentrum München and the University Hospital of LMU Munich show that deep learning algorithms perform similar to human experts when classifying blood samples from patients suffering from acute myeloid leukemia (AML). Their proof of concept study paves the way for an automated, standardized and on-hand sample analysis in the near future. The paper was…
If a health sector employee falls ill with a bloodborne illness, the cause is often a previous injury from a sharp, contaminated object. Direct blood-to-blood contact, such as with an NSI, is one of the recurring causes of infection. It isn’t possible to vaccinate against HIV, for instance, and the consequences of an infection remain fatal. Don’t take the dangers posed by NSI lightly: get…
A photonics tech company from Vilnius are on their path to solve the 50-year-old task of making non-invasive blood analysis possible. With the help of a unique broadband laser-based sensor, the scientists and engineers at Brolis Sensor Technology are able to remotely sense concentration level of main critical blood constituents such as lactate, glucose, urea, ketones or ethanol without drawing…
T2 Biosystems and CARB-X announced that the T2Resistance Panel is the first diagnostic to graduate from CARB-X’s portfolio.
